Literature DB >> 11853189

Identification and determination of salicylic acid and salicyluric acid in urine of people not taking salicylate drugs.

G J Baxter1, J R Lawrence, A B Graham, D Wiles, J R Paterson.   

Abstract

BACKGROUND: Salicylic acid (SA) is present in the serum of people who have not taken salicylate drugs. Now we have examined the urine of these subjects and found that it contains SA and salicyluric acid (SU). We have established the identities of these phenolic acids and determined their concentrations. METHODS AND
RESULTS: The acidic hydrophobic compounds of urine were separated using high-performance liquid chromatography (HPLC) and were detected and quantified electrochemically. Two approaches were used to establish the identity of SA and SU. First, the retention times (Rt) of the substances extracted and those of SA and SU were compared under two sets of chromatographic conditions; the Rt of the compounds suspected to be SA and SU and those of the authentic substances were very similar under both sets of conditions. Second, the unknown substances, isolated by HPLC, were treated with acetyl chloride in methanol and compared with the methyl esters of SA and SU by using gas chromatography-mass spectrometry; the unknown compounds after esterification had very similar mass spectra and gas chromatographic R, to those of methyl salicylate and methyl salicylurate. The median (n = 10) urinary concentration of SA was 0.56 micromol/L (range 0.07-0.89 micromol/L) and that of SU was 3.20 micromol/L (range 1.32-6.54 micromol/L). SA and its major urinary metabolite, SU, were found in the urine of all of the 10 people examined.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11853189     DOI: 10.1258/0004563021901739

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  5 in total

1.  Serum salicylate levels and risk of recurrent colorectal adenomas.

Authors:  Aasma Shaukat; Maria V Grau; Timothy R Church; Gwen Baxter; Elizabeth L Barry; Robert Summers; Robert S Sandler; John A Baron
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-02-09       Impact factor: 4.254

2.  Urinary excretion of salicyluric and salicylic acids by non-vegetarians, vegetarians, and patients taking low dose aspirin.

Authors:  J R Lawrence; R Peter; G J Baxter; J Robson; A B Graham; J R Paterson
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

3.  Effect of low salicylate diet on clinical and inflammatory markers in patients with aspirin exacerbated respiratory disease - a randomized crossover trial.

Authors:  Leigh J Sowerby; Krupal B Patel; Crystal Schmerk; Brian W Rotenberg; Taciano Rocha; Doron D Sommer
Journal:  J Otolaryngol Head Neck Surg       Date:  2021-04-23

4.  Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients).

Authors:  Hamzah Khan; Abdelrahman Zamzam; Reid C Gallant; Muzammil H Syed; Margaret L Rand; Heyu Ni; Thomas L Forbes; Mohammed Al-Omran; Mohammad Qadura
Journal:  Res Pract Thromb Haemost       Date:  2021-11-16

5.  Salicylic acid sans aspirin in animals and man: persistence in fasting and biosynthesis from benzoic acid.

Authors:  John R Paterson; Gwendoline Baxter; Jacob S Dreyer; John M Halket; Robert Flynn; James R Lawrence
Journal:  J Agric Food Chem       Date:  2008-12-24       Impact factor: 5.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.